Skip to main content
Saturday
November 02, 2024
Sign In
Subscribe
Home
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
Podcast
World+Biz
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Tech
Magazine
Climate Change
Health
Cartoons
বাংলা
SATURDAY,
NOVEMBER 02, 2024
Novavax Covid-19 Vaccine
Coronavirus chronicle
US FDA authorizes Novavax Covid vaccine for adults
Coronavirus chronicle
Novavax Covid-19 vaccine gets first authorization; expects more within weeks, CEO says
Coronavirus chronicle
India allows Serum Institute to enrol 7-11 year olds in Novavax Covid-19 vaccine trial
Coronavirus chronicle
Novavax begins early-stage trial for combined influenza/Covid-19 vaccine
Coronavirus chronicle
EU seals deal with Novavax for up to 200 million Covid-19 vaccines
Coronavirus chronicle
India might approve Novavax in 2 months, likely to cost more than Covishield: CEO
Coronavirus chronicle
SII to introduce Novavax vaccine in India by September
Coronavirus chronicle
Novavax vaccine efficacy data promising; trials in advanced stage: Indian govt
Coronavirus chronicle
Novavax Covid vaccine to be made by Serum Institute, shows 90% efficacy
Coronavirus chronicle
Novavax Covid-19 vaccine more than 90% effective in US trial
Coronavirus chronicle
Novavax says supply shortages delaying full-speed production of its Covid-19 vaccine
Coronavirus chronicle
Novavax starts allowing participants on placebo to get Covid-19 vaccine in trials
Coronavirus chronicle
Novavax delays EU vaccine supply deal amid production problems - source
Show More